-
1دورية أكاديمية
المؤلفون: Sally A. Hulton, Jaap W. Groothoff, Yaacov Frishberg, Michael J. Koren, J. Scott Overcash, Anne-Laure Sellier-Leclerc, Hadas Shasha-Lavsky, Jeffrey M. Saland, Wesley Hayes, Daniella Magen, Shabbir H. Moochhala, Martin Coenen, Eva Simkova, Sander F. Garrelfs, David J. Sas, Kristin A. Meliambro, Taylor Ngo, Marianne T. Sweetser, Bahru A. Habtemariam, John M. Gansner, Tracy L. McGregor, John C. Lieske
المصدر: Kidney International Reports, Vol 7, Iss 3, Pp 494-506 (2022)
مصطلحات موضوعية: lumasiran, nephrocalcinosis, phase 3 clinical trial, primary hyperoxaluria type 1, RNA interference, urinary oxalate, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
2
المؤلفون: Benjamin O. Adegbite, Matthew H. Abramson, Victoria Gutgarts, Marcel F. Musteata, Kinsuk Chauhan, Alecia N. Muwonge, Kristin A. Meliambro, Steven P. Salvatore, Sebastian El Ghaity-Beckley, Marina Kremyanskaya, Bridget Marcellino, John O. Mascarenhas, Kirk N. Campbell, Lili Chan, Steven G. Coca, Ellin M. Berman, Edgar A. Jaimes, Evren U. Azeloglu
المصدر: medRxiv
مصطلحات موضوعية: Article
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b094cfad1cf08e41e114ad9f348c8aa1
https://europepmc.org/articles/PMC10153335/ -
3
المؤلفون: Sally A. Hulton, Jaap W. Groothoff, Yaacov Frishberg, Michael J. Koren, J. Scott Overcash, Anne-Laure Sellier-Leclerc, Hadas Shasha-Lavsky, Jeffrey M. Saland, Wesley Hayes, Daniella Magen, Shabbir H. Moochhala, Martin Coenen, Eva Simkova, Sander F. Garrelfs, David J. Sas, Kristin A. Meliambro, Taylor Ngo, Marianne T. Sweetser, Bahru A. Habtemariam, John M. Gansner, Tracy L. McGregor, John C. Lieske
المساهمون: Paediatric Nephrology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction & Development (AR&D), Graduate School, APH - Methodology, APH - Quality of Care
المصدر: Kidney International Reports, 7(3), 494-506. Elsevier Inc.
مصطلحات موضوعية: urinary oxalate, RNA interference, phase 3 clinical trial, Nephrology, primary hyperoxaluria type 1, nephrocalcinosis, lumasiran